Rituximab therapy for the type B syndrome of severe insulin resistance

N Engl J Med. 2004 Jan 15;350(3):310-1. doi: 10.1056/NEJM200401153500324.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies / blood
  • Female
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hyperglycemia / blood
  • Hyperglycemia / drug therapy*
  • Hyperglycemia / immunology
  • Immunoglobulin G / blood
  • Insulin Resistance* / immunology
  • Receptor, Insulin / immunology
  • Rituximab
  • Syndrome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies
  • Glycated Hemoglobin A
  • Immunoglobulin G
  • Rituximab
  • Receptor, Insulin